| RS1792043667 |
COL1A2
|
Health Risk |
Likely pathogenic |
— |
| RS1792043985 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS1792044352 |
COL1A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1792048079 |
SLC25A13
|
Health Risk |
Pathogenic/Likely pathogenic |
Citrin deficiency, Neonatal intrahepatic cholestasis due to citrin deficiency |
| RS1792049376 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1792051187 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, CFTR-related disorder |
| RS1792080911 |
GUSB
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 7, Mucopolysaccharidosis type 7 |
| RS1792099468 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Cystic fibrosis |
| RS1792099971 |
CFTR
|
Health Risk |
Pathogenic |
— |
| RS1792100143 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, CFTR-related disorder |
| RS1792102061 |
PEX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Zellweger spectrum disorders, Heimler syndrome 1 |
| RS1792104355 |
PEX1
|
Health Risk |
Likely pathogenic |
— |
| RS1792108068 |
COL1A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1792108270 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1792111046 |
PEX1
|
Health Risk |
Likely pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS1792111444 |
PEX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 1A (Zellweger), Heimler syndrome 1 |
| RS1792120689 |
ASNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome, Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome |
| RS1792123022 |
ASNS
|
Health Risk |
Pathogenic |
ASNS-related disorder, ASNS-related disorder |
| RS1792124597 |
ASNS
|
Health Risk |
Likely pathogenic |
— |
| RS1792127580 |
ARID1B
|
Health Risk |
Pathogenic |
— |
| RS1792139807 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1792140365 |
SAMD9L
|
Health Risk |
Pathogenic |
Monosomy 7 myelodysplasia and leukemia syndrome 1, Monosomy 7 myelodysplasia and leukemia syndrome 1 |
| RS1792140624 |
COL1A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1792142540 |
SLC26A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 4, Pendred syndrome |
| RS1792147522 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS1792148801 |
COL1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, arthrochalasia type |
| RS1792149726 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1792149902 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1792186595 |
PEX1
|
Health Risk |
Likely pathogenic |
Zellweger spectrum disorders, Peroxisome biogenesis disorder 1B |
| RS1792213890 |
SAMD9L
|
Health Risk |
Likely pathogenic |
Ataxia-pancytopenia syndrome, Ataxia-pancytopenia syndrome |
| RS1792222710 |
PEX1
|
Health Risk |
Pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS1792226793 |
SAMD9L
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1792246412 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1792256171 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1792257312 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1792258600 |
AUTS2
|
Health Risk |
Pathogenic |
Autism spectrum disorder due to AUTS2 deficiency, Autism spectrum disorder due to AUTS2 deficiency |
| RS1792259695 |
COL1A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1792269292 |
COL1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1792298693 |
COL1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS1792305947 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
CFTR-related disorder, Cystic fibrosis |
| RS1792307406 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Hereditary pancreatitis |
| RS1792308325 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS1792353123 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS1792366769 |
CFTR
|
Health Risk |
Pathogenic/Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1792377306 |
COG5
|
Health Risk |
Likely pathogenic |
COG5-congenital disorder of glycosylation, COG5-congenital disorder of glycosylation |
| RS1792456313 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1792456337 |
CFTR
|
Health Risk |
Pathogenic/Likely pathogenic |
Cystic fibrosis, Bronchiectasis with or without elevated sweat chloride 1 |
| RS1792478147 |
ARID1B
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS1792596054 |
PEX1
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder, Zellweger spectrum disorders |
| RS1792647486 |
CFTR
|
Health Risk |
Pathogenic |
Bronchiectasis with or without elevated sweat chloride 1, Cystic fibrosis |
| RS1792671655 |
CFTR
|
Health Risk |
Pathogenic/Likely pathogenic |
Cystic fibrosis, Bronchiectasis with or without elevated sweat chloride 1 |
| RS1792676538 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1792801432 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |
| RS1792814581 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrin deficiency, Citrin deficiency |
| RS1792826036 |
KCND2
|
Health Risk |
Pathogenic/Likely pathogenic |
Early myoclonic encephalopathy, Neurodevelopmental disorder |
| RS1792847005 |
PEX1
|
Health Risk |
Pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS1792857897 |
PEX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Zellweger spectrum disorders, Heimler syndrome 1 |
| RS1792860966 |
PEX1
|
Health Risk |
Pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS1792861698 |
PEX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS1792868421 |
PEX1
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 1B, Peroxisome biogenesis disorder 1A (Zellweger) |
| RS1792878019 |
PEX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Zellweger spectrum disorders, Peroxisome biogenesis disorder 1A (Zellweger) |
| RS1792914342 |
SBDS
|
Health Risk |
Pathogenic |
Shwachman-Diamond syndrome 1, Shwachman-Diamond syndrome 1 |
| RS1792929407 |
RALA
|
Health Risk |
Likely pathogenic |
— |
| RS1792935619 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1792935893 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, CFTR-related disorder |
| RS1792936385 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1792969582 |
SBDS
|
Health Risk |
Pathogenic |
Shwachman-Diamond syndrome 1, Inborn genetic diseases |
| RS1793014648 |
SBDS
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1793018926 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS1793020065 |
POLR1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypomyelinating leukodystrophy 11, Hypomyelinating leukodystrophy 11 |
| RS1793020074 |
TRRAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1793021342 |
POLR1C
|
Health Risk |
Pathogenic/Likely pathogenic |
Treacher Collins syndrome 3, Hypomyelinating leukodystrophy 11 |
| RS1793049226 |
EYA4
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1J, Dilated cardiomyopathy 1J |
| RS1793062463 |
POLR1C
|
Health Risk |
Pathogenic |
— |
| RS1793074319 |
PEX1
|
Health Risk |
Likely pathogenic |
Zellweger spectrum disorders, Heimler syndrome 1 |
| RS1793076195 |
PEX1
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS1793076317 |
PEX1
|
Health Risk |
Pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS1793080553 |
SBDS
|
Health Risk |
Likely pathogenic |
Aplastic anemia, Aplastic anemia |
| RS1793090227 |
PDE8B
|
Health Risk |
Likely pathogenic |
Autosomal dominant striatal neurodegeneration type 1, Autosomal dominant striatal neurodegeneration type 1 |
| RS1793092853 |
ELN
|
Health Risk |
Pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS1793108213 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, CFTR-related disorder |
| RS1793110279 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1793228690 |
ARID1B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1793246524 |
ARID1B
|
Health Risk |
Pathogenic |
— |
| RS1793251352 |
ARID1B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1793254982 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1793298143 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1793304372 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS1793342111 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1793379665 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS1793383674 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS1793395260 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Cystic fibrosis |
| RS1793398163 |
RNF216
|
Health Risk |
Pathogenic |
— |
| RS1793398751 |
PEX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Zellweger spectrum disorders, Peroxisome biogenesis disorder 1A (Zellweger) |
| RS1793402720 |
PEX1
|
Health Risk |
Pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS1793524609 |
TRRAP
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental delay with or without dysmorphic facies and autism, Hearing loss |
| RS1793536857 |
ERMARD
|
Health Risk |
Likely pathogenic |
Periventricular nodular heterotopia 6, Periventricular nodular heterotopia 6 |
| RS1793561613 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1793597181 |
KRIT1
|
Health Risk |
Pathogenic |
— |
| RS179363866 |
IKBKG
|
Health Risk |
Pathogenic |
Immunodeficiency 33, Immunodeficiency 33 |